Search

Background: The occurrence and progression of breast cancer are closely linked to copper ion homeostasis. Both copper deficiency and excess can inhibit breast cancer growth, while copper transport systems may contribute to its progression by regulating copper ion transport and the activity of associated proteins. However, a comprehensive review of the roles and applications of copper transport systems in breast cancer remains limited. In this study, we summarize the workflow of copper transport systems and the dual role of copper in cancer, highlighting the contributions of specific members of the copper transport system to breast cancer. Methods: A comprehensive search of the PubMed database was conducted to identify articles published over the past 30 years that focus on the relationship between copper transport system members and breast cancer. The findings were synthesized to elucidate the roles and mechanisms of these transporters in the onset and progression of breast cancer. Results: We identified 13 members of the copper transport system associated with the occurrence, progression, and mortality of breast cancer, including SLC31A1, DMT1, ATP7A, ATP7B, MTs, GSH, ATOX1, CCS, COX17, SCO1, SCO2, and COX11. Our findings revealed that, apart from STEAP, the remaining 12 members were overexpressed in breast cancer. These members influence the onset, progression, and cell death of breast cancer by modulating biological pathways such as intracellular copper ion levels and ROS. Notably, we observed for the first time that depletion of the copper storage protein GSH leads to increased copper ion accumulation, resulting in cuproptosis in breast cancer cells. Conclusion: By integrating the members of the copper transport system in breast cancer, we offer novel insights for the treatment of breast cancer and copper‐related therapies. [ABSTRACT FROM AUTHOR]

Introduction: Chemo-immunotherapy based on inducing tumor immunogenic cell death (ICD)with chemotherapy drugs has filled the gaps between traditional chemotherapy and immunotherapy. It is verified that paclitaxel (PTX) can induce breast tumor ICD. From this basis, a kind of nanoparticle that can efficiently deliver different drug components simultaneously is constructed. The purpose of this study is for the sake of exploring the scheme of chemotherapy-induced ICD combined with other immunotherapy to enhance tumor immunogenicity and inhibit the growth, metastasis, and recurrence of breast tumors, so as to provide a research basis for solving the tough problem of breast cancer treatment. Methods: Nanomedicine loaded with PTX, small interference RNA that suppresses CD47 expression (CD47siRNA, siCD47), and immunomodulator R848 were prepared by the double emulsification method. The hydrodynamic diameter and zeta potential of NP/PTX/siCD47/R848 were characterized. Established the tumor-bearing mice model of mouse breast cancer cell line (4T1) in situ and observed the effect of intravenous injection of NP/PTX/siCD47/R848 on the growth of 4T1 tumor in situ. Flow cytometry was used to detect the effect of drugs on tumor immune cells. Results: NP/PTX/siCD47/R848 nano-drug with tumor therapeutic potential were successfully prepared by double emulsification method, with particle size of 121.5 ± 4.5 nm and surface potential of 36.1 ± 2.5 mV. The calreticulin on the surface of cell membrane and extracellular ATP or HMGB1 of 4T1 cells increased through treatment with NPs. NP/PTX-treated tumor cells could cause activation of BMDCs and BMDMs. After intravenous injection, NP/PTX could quickly reach the tumor site and accumulate for 24 h. The weight and volume of tumor in situ in the breast cancer model mice injected with nanomedicine through the tail vein were significantly lower than those in the PBS group. The ratio of CD8+/CD4+ T cells in the tumor microenvironment and the percentage of dendritic cells in peripheral blood increased significantly in breast cancer model mice injected with nano-drugs through the tail vein. Discussion: Briefly, the chemotherapeutic drug paclitaxel can induce breast cancer to induce ICD. The nanomedicine which can deliver PTX, CD47siRNA, and R848 at the same time was prepared by double emulsification. NP/PTX/siCD47/R848 nano-drug can be enriched in the tumor site. The experiment of 4T1 cell tumor-bearing mice shows that the nano-drug can enhance tumor immunogenicity and inhibit breast tumor growth, which provides a new scheme for breast cancer treatment. (Graphical abstract) Intravenous injection of PTX-loaded nanomedicine based on PEG-PLGA causes immunogenic death of tumor cells and simultaneously reduces tumor cell immune escape, promotes macrophage polarization towards MI subtypes, and effectively activates DCs, thereby enhancing anti-tumor immunity. [ABSTRACT FROM AUTHOR]

Introduction Congenital heart disease (CHD) occurs in ~1% of newborns in the United States. (1,2) This disease can arise from many distinct etiologies that elicit diverse cellular and molecular responses [...], Objectives: We evaluated the effects of Cd on the different stages (mesoderm, cardiac induction, cardiac function) of cardiac development using an early embryo development in vitro model and two- or three-dimensional (2- or 3D) cardiomyocyte and cardiac organoid formation models mimicking early cardiac development. Methods: Embryonic stem cells (ESCs) form 3D aggregates, called embryoid bodies, that recapitulate events involved with early embryogenesis (e.g., germ layer formation). This model was used for early germ layer formation and signaling pathway identification. The 2D cardiomyocyte differentiation from the NKX2-[5.sup.eGFP/w] human ESCs model was used to explore the effects of Cd exposure on cardiomyocyte formation and to model mesoderm differentiation and cardiac induction, allowing us to explore different developmental windows of Cd toxicity. The 3D cardiac organoid model was used in evaluating the effects of Cd exposure on contractility and cardiac development. Results: Cd (0.6 [micro]M; 110ppb) lowered the differentiation of embryoid bodies to mesoderm via suppression of Wnt/[beta]-catenin-signaling pathways. During early mesoderm induction, the mesoderm-associated transcription factors MESP1 and EOMES showed a transient up- regulation, which decreased later in the cardiac induction stage. Cd (0.15 [micro]M) lowered mesoderm formation and cardiac induction through suppression of the transcription factors and mesoderm marker genes HAND1, SNAI2, HOPX, and the cardiac-specific genes NKX2-5, GATA4, troponin T, and alpha-actinin. In addition, Cd-induced histone modifications for both gene activation (H3K4me3) and repression (H3K27me3), which play vital roles in regulating mesoderm commitment markers. The effects of Cd inhibition on cardiomyocyte differentiation were confirmed in 3D cardiac organoids. Discussion: In conclusion, using a human ESC-derived 2D/3D in vitro differentiation model system and cardiac organoids, we demonstrated that low-dose Cd suppressed mesoderm formation through mesoderm gene histone modification, thus inhibiting cardiomyocyte differentiation and cardiac induction. The studies provide valuable insights into cellular events and molecular mechanisms associated with Cd- induced congenital heart disease. https://doi.org/10.1289/EHP11208

Dopamine (DA) is a crucial neurotransmitter in the central nervous system (CNS) of human and multicellular animal brains. In this paper, we report for the first time the synthesis of carbon black (C)/phosphotungstic acid (PWA) composites by doping PWA on carbon black nanoparticles by impregnation method. The synthesized materials were characterized using high‐resolution scanning electron microscopy (SEM), X‐ray diffraction spectroscopy (XRD) and Fourier transform infrared spectroscopy (FT‐IR). Glassy carbon electrodes (GCE) modified by C/PWA composites were used to detect dopamine. The electrochemical redox behavior of DA was studied with cyclic voltammetry (CV). Under optimized conditions, DA was detected by differential pulse voltammetry (DPV) and the calibration plot showed linearity (R2=0.9988) over the range of DA concentrations of 10 μM‐600 μM with a detection limit of 0.1 μM. The sensor's capability to detect DA in commercial DA injections in real time has been successfully demonstrated. [ABSTRACT FROM AUTHOR]

As a classical sparse reconstruction algorithm, iterative soft thresholding (IST) is often used in SAR sparse imaging applications. However, for moving targets, the radar echo contains an unknown phase error, so it is difficult to directly apply the IST algorithm to reconstruct the SAR moving target image. In this article, a parametric IST (P-IST) algorithm is proposed for refocusing of moving targets in synthetic aperture radar (SAR) images. In this algorithm, the echo phase error is modeled as a function of the phase compensation factor, and in the iteration process, a phase compensation factor optimization selection step based on residual energy minimization is added. Compared with the existing algorithms, the proposed P-IST algorithm can obtain the global optimal solution and has better efficiency and robustness. Both simulated data and measured data are used to validate the effectiveness of the proposed algorithm. [ABSTRACT FROM AUTHOR]

Ofloxacin (OFL) has antibacterial and anti‐inflammatory effects on respiratory tract infection, skin soft tissue infection and urogenital tract infection caused by sensitive bacteria. In this study, an electrochemical sensor on account of glassy carbon electrode (GCE) and anthraquinone (AQ)/Vulcan XC‐72 (C) composite was prosperity prepared for the determination of ofloxacin (OFL) drug. The morphology and structure of C/20%AQ composites were characterized by SEM. The electrochemical behavior of OFL on the C/20%AQ/GCE sensor was tested using differential pulse voltammetry (DPV) and cyclic voltammetry (CV). The consequences indicate that the linear response of the sensor to OFL at pH 6.5 in 0.2 M phosphate buffer solution (PBS) was in the scope of 0.1–550.0 μM (R2=0.998) with the limit of detection of 0.01 μM. The prepared C/20%AQ/GCE sensor exhibited good anti‐interference ability and repeatability against OFL. The sensor presents a sensitive, simple and low cost OFL detection method, and has been successfully applied to real samples. [ABSTRACT FROM AUTHOR]